Articles tagged with Stem Cells
A team of bioengineers at Rice University is developing new materials to grow replacement heart valves using gel-like scaffolds that mimic the complex structure and physical properties of heart-valve tissues. The goal is to create living valves that use a patient's own cells, eliminating tissue rejection.
Experts recommend collecting peripheral blood stem cells from Fukushima radiation workers to prepare for potential future stem cell transplants. This technique has several advantages over allogeneic transplantation, including reducing the risk of graft-versus-host disease and immunosuppression.
Cardiac stem cell treatment is being explored as an option for treating heart failure. Dr. Bolli's study, SCIPIO, aims to perfect a technique using a patient's own cardiac stem cells to regenerate dead heart muscle after a heart attack. Results show promising improvements in patients' physical capabilities and ejection fraction.
Researchers have successfully treated severe Crohn's disease with a new cell therapy approach using Type 1 regulatory lymphocytes. The preliminary results indicate improved condition and good tolerability, paving the way for further phase 2b clinical trials.
A long-term study reports the effectiveness of stem cell transplants in replacing bone marrow and reducing disease activity in people with rapidly progressive MS. The treatment showed promising results, with an average improvement in symptoms lasting two years.
A study published in Blood reveals a close relationship between pulmonary arterial hypertension and myeloid abnormalities in the bone marrow. The researchers found that blood progenitor cells are increased in patients with PAH, suggesting an abnormal feedback loop connecting blood and lung cell behavior.
Researchers describe the mechanism of blockade and reactivation in molecular detail, revealing TFIIS's role in facilitating mRNA excision. This process is essential for cell survival and regulates gene activity in stem and tumor cells.
Researchers have created a bioengineered protein called CD19-L that selectively targets and destroys leukemia cells, including those resistant to chemotherapy. This breakthrough discovery offers new hope for treating childhood leukemia.
Two studies investigate the role of bone marrow stem cells in diabetic therapy and islet cell regeneration, offering new therapeutic possibilities. Researchers also focus on improving pancreatic islet culture and preservation techniques to prolong the survival and functionality of islet cells in vitro.
The research team used single-molecule imaging to study G protein-coupled receptors (GPCRs) and found that they can interconvert between monomers and dimers. This understanding is crucial for predicting GPCR numbers in cells and blocking signal amplification by these molecules.
A team of scientists created a programable molecular transport system, observed in real time using atomic force microscopy. The system consists of a DNA origami track with a motor and fuel, allowing for adjustable speed and potential applications in drug delivery and synthetic ribosome creation.
Researchers at Kyoto University have developed a porous framework that can capture common air pollutants and emit glowing colors when exposed to ultraviolet light. This breakthrough enables the creation of portable, solid-state pollution detectors with potential applications in medicine, pharmaceuticals, and industry.
UCSF researchers developed a new approach to examine how cells convert DNA into RNA, bridging a gap in understanding gene expression. The technique enables direct observation of the transcription process at unprecedented resolution, providing insights into gene regulation and function.
A team of researchers from University of Missouri and Columbia University successfully regenerates complete shoulder joint surfaces in animals using the patient's own cells. The new technique eliminates the need for multiple surgeries to harvest and implant cells, making it a promising alternative to metal and plastic joints.
Researchers at UCLA's Jonsson Comprehensive Cancer Center have found a new mechanism that regulates protein stability in cells, triggered by the GSK3 enzyme. This discovery could lead to potential new treatments for cancer, particularly colorectal cancers and other forms of cancer.
Researchers found that human CML stem cells do not rely on BCR-ABL activity for survival, rendering traditional treatments ineffective. This breakthrough highlights the need for new therapeutic strategies to target these resilient cancer cells.
Researchers found that Duchenne muscular dystrophy symptoms emerge when skeletal muscle stem cells can no longer keep up with repairs, leading to progressive muscle weakening and respiratory failure. Successful treatments targeting muscle stem cells may alleviate symptoms and offer new hope for managing the disease.
A new mouse model of Duchenne muscular dystrophy suggests that muscle stem cells are key to understanding the disease's progression. The research found that mice with a similar mutation to humans experience severe muscle weakness and shortened life spans due to the inability of their muscle stem cells to keep up with ongoing damage.
Tel Aviv University researchers discovered that endurance exercises increase muscle stem cells and enhance their ability to rejuvenate old muscles. This finding could lead to a new drug to help the elderly and immobilized heal their muscles faster.
Researchers discovered a protein necessary for normal cell division in blood-forming stem cells, which resulted in abnormal numbers of chromosomes and high rates of cell death. This finding highlights the metabolic differences between stem cells and other blood-forming cells.
Researchers at Rockefeller University Press have successfully reprogrammed human skin cells to produce platelets that can be used in patients with thrombocytopenia. The breakthrough method involves culturing these cells in a cocktail of platelet-promoting factors, resulting in platelets that function like normal healthy platelets.
A new study suggests that fat-derived stem cells can safely improve heart function after a heart attack by reducing damaged tissue, increasing blood flow, and boosting the heart's pumping ability. The treatment was found to be effective in patients with severe heart attacks, but further research is needed to confirm its efficacy.
A mathematical model developed by researchers at Massachusetts General Hospital and Harvard University can predict the risk of anemia in individuals. The model reflects how red blood cells change in size and hemoglobin content during their four-month lifespan, allowing for early detection of iron-deficiency anemia.
A University of Colorado at Boulder-led study found that specific stem cells can prevent the loss of muscle function and mass with aging. The transplanted stem cells doubled in mass and sustained themselves for two years, suggesting a potential treatment for humans with chronic degenerative muscle diseases.
A phase I clinical trial at University of Texas M. D. Anderson Cancer Center found an antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma.
Researchers found daily whole body vibration improves bone density around the hip joint and femur, reducing a biomarker of bone breakdown. The technique also stimulates stem cells to differentiate into bone cells, potentially aiding fracture healing. Vibration has shown promise in improving glucose uptake and reducing fatty liver disease.
A new method for molecular imaging in cells using CARS technique reduces power levels while increasing speed, enabling detailed molecular maps without damaging cells. This breakthrough opens the door for widespread use of vibrational spectroscopy in biology and clinical diagnosis.
Engineered 'firefly' stem cells can help repair damaged hearts without cutting into patients' chests. Researchers can now track the cells' progress using a special camera lens that picks up the glow under a microscope.
The annual Stem Cells Young Investigator Award is presented to a young scientist who published an important paper in the journal. The award recognizes innovative young investigators making significant contributions to stem cell biology and applications.
Researchers have developed an in vitro system to investigate hair-cell regeneration techniques, while studies also examine the presence of biofilms in chronic rhinosinusitis with nasal polyps. Disparities in healthcare access and utilization among children with ear infections were also found, highlighting the need for targeted interven...
Research at OHSU's Vaccine and Gene Therapy Institute suggests that G-CSF, a hormone stimulating stem cell growth, can reactivate human cytomegalovirus in bone marrow recipients, increasing their risk of infection. The study highlights the need for factoring in the risks associated with G-CSF use during transplants.
Researchers at IRCM discover a protein called Gfi1b that regulates blood stem cell activity and mobilization, potentially accelerating the production of new blood cells. This breakthrough could lead to more efficient and safer stem cell therapy for leukemia patients.
A study published in Cell Stem Cell reveals that NURF, an enzyme that regulates DNA packaging, allows specific genes to be turned on and off in stem cells. This dynamic structure enables stem cells to maintain their potency and prevent differentiation into other cell types.
The University of South Florida researchers warn that the growing number of stem cell journals may compromise the quality of research in the field. They recommend authors to follow Good Publications Practices when choosing a publication outlet.
Scientists have identified a population of cells enriched with the capacity to regenerate blood vessels, which show promise in treating cardiovascular disease. These cells, isolated from human blood or bone marrow, can support the growth of nearby blood vessels and enhance blood flow.
Researchers at Duke University have developed a method for injecting substances into single cells using sharp fluid jets, which may revolutionize stem cell research and cellular-level studies. The technique allows for the introduction of live cells to nontoxic substances without significantly damaging them.
The researchers created a library of micromolded, hexagonally spaced elastomeric micropost arrays to study the effects of substrate flexibility on stem cell development and adhesion. The system allowed them to modulate the rigidity and flexibility of the substrate surface without changing its adhesive properties.
Researchers at UT Southwestern Medical Center discovered a tiny RNA fragment, miR-451, that regulates red blood cell production. By inhibiting this process, they hope to develop new treatments for cancers and anemia.
A pioneering study has shown that joints can be regrown using a host's own stem cells, potentially leading to longer-lasting artificial joint replacements. The work provides a proof-of-concept for naturally grown joints and may lead to clinical applications in the future.
Researchers implanted genetically engineered stem cells with cytokines HGF, SDF-1, and VEGF to reduce organ damage and improve cardiac function after a heart attack. The results showed that two therapies - SDF-1 and Akt1 overproduction - limited cardiac damage.
A new generation of biological scaffolds enables the development of off-the-shelf tissue transplants that can be repaired and renewed like normal tissue. The technique removes cells from natural tissues to leave a biocompatible scaffold made of collagen, allowing patients' own cells to populate and bind to it.
Italian scientists have successfully completed preclinical trials for a gene transfer treatment that can correct the lack of beta-globin in patients' blood cells, a major step towards treating beta-thalassemia. The treatment uses genetically corrected stem cells to restore haemoglobin production and overcome the disorder.
A multicentric clinical phase II study led by Professor Dr. Peter Dreger found that allogeneic stem cell transplantation significantly improved tolerance and cured nearly half of patients with therapy-resistant chronic leukemia, regardless of genetic risk profile or prior treatment outcomes.
A new DNA delivery method has been discovered by Virginia Tech chemical engineers, which enhances the delivery of genetic material into cells. The method uses hydrodynamic effects to uniformly deliver DNA over the entire cell surface, resulting in a greatly enhanced transfer of genetic material.
A study found that more than 40% of patients with treatment-resistant CLL enjoyed long-term freedom from relapse after receiving allogeneic stem cell transplants. The transplants were associated with significant risks but offered a potential cure for this patient population.
Researchers discovered a key regulator of spermatogonial stem cell self-renewal by manipulating the STAT3 protein. This process may be linked to degenerative diseases in humans, highlighting the importance of understanding stem-cell activity in disease prevention and treatment.
A recent study published in Nature found that auxin and cytokinin, two previously thought-to-be antagonistic plant growth hormones, actually cooperate to regulate plant growth. The international team of researchers discovered that auxin boosts the effect of cytokinin by suppressing genes that limit its activity.
Researchers have successfully extracted stem cells from sections of vein removed for heart bypass surgery, which can stimulate new blood vessels to grow and potentially help repair damaged heart muscle after a heart attack. The discovery brings the possibility of 'cell therapy' for damaged hearts one step closer.
A new clinical trial, IMPACT-CABG, evaluates the safety and efficacy of injecting stem cells into the hearts of patients undergoing coronary bypass surgery. The study aims to promote healing and regeneration of damaged heart muscle, offering a less invasive alternative to heart transplant.
Researchers at Cedars-Sinai Heart Institute have developed a method to guide cardiac stem cells using micro-size iron particles and a magnet, increasing retention in the injured area and enhancing heart function. This innovative technique shows great promise for improving the effectiveness of stem cell therapies for heart disease.
A novel stem cell therapy has been developed to arm the immune system against HIV, potentially improving quality of life and life expectancy for those who have failed antiviral drugs. The therapy involves delivering antiviral DNA to patient immune cells, which can block viral gene production using RNA interference.
Researchers have discovered that infantile hemangiomas originate from stem cells. Steroids target these stem cells specifically, inhibiting their ability to stimulate blood vessel growth. This finding opens the way for more specific and safer therapies for hemangioma.
Researchers at Northwestern University characterized a special type of stem cell, endothelial progenitor cells (EPCs), to see if they can behave as endothelial cells in the body when cultured on a bioengineered surface. The study shows promise for improving surgery success rates for peripheral arterial disease.
Researchers identify a new reservoir for hidden HIV-infected cells in bone marrow, which can serve as a factory for new infections. The discovery opens up new possibilities for treating HIV, particularly for individuals who have been taking anti-viral drugs for their entire life.
Researchers at Rensselaer Polytechnic Institute have developed a new method to predict the fate of stem cells using advanced computer vision technology. With up to 99 percent accuracy, this method can forecast how cells will divide and what characteristics their daughter cells will exhibit.
Scientists at Rhode Island Hospital have discovered a novel mechanism of cell-to-cell communication using microvesicles, which can reprogram stem cells to behave like healthy cells. This finding offers hope for tissue regeneration and potential treatments for diseases such as cancer.
Researchers at UCLA successfully removed CCR5 receptor, which HIV binds to, from human immune cells using a gene-based approach. This strategy shows promise for treating HIV-infected individuals by reducing the virus's ability to infect cells.
Researchers evaluated cord blood-derived CD133+ cells for treating myocardial infarction. The cells showed promising results, improving left ventricular ejection fraction and forming tubule-like structures. Further pre-clinical testing is needed to determine their clinical advantages.
Scientists have discovered a mechanism by which yeast cells transport damaged proteins to mother cells using conveyor-like structures called actin cables. This process ensures that newly formed daughter cells are born without age-related damage, paving the way for potential treatments of age-related diseases.
Researchers at the University of Melbourne discovered a type of cell that causes T cell Acute Lymphoblastic Leukaemia in children. Targeting these cells could reduce treatment length and toxicity, leading to better patient outcomes.